Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,37578,1527,1.03 [0.94-1.14],0.5166639155290937
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,37008,360,1.07 [0.87-1.31],0.5068955500513765
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,40977,275,1.21 [1.00-1.47],0.0527612463078002
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,28312,1281,1.06 [0.95-1.19],0.2693397972523557
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,40886,184,1.16 [0.90-1.49],0.2490288554530819
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,38349,145,1.05 [0.77-1.44],0.744402311017299
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",42935,182,1.14 [0.88-1.47],0.3208950857267376
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,42942,124,1.24 [0.94-1.64],0.132027815554141
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,37460,94,1.15 [0.80-1.65],0.4410460551629915
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,41616,200,0.98 [0.74-1.30],0.8713251855454682
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other septicaemia,41544,128,0.96 [0.67-1.37],0.8185130912876695
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43060,117,0.98 [0.68-1.41],0.9265915482659484
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other viral diseases,43063,143,1.17 [0.89-1.54],0.257479490973033
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43053,133,1.20 [0.91-1.57],0.2011972114610153
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Mycoses,42503,93,1.23 [0.89-1.70],0.2170430699588065
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",41063,682,0.84 [0.70-1.00],0.0453675543724991
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,40617,236,0.70 [0.50-0.97],0.031923551241686
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,40850,469,0.86 [0.70-1.06],0.1523432466117185
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",34572,109,1.26 [0.94-1.69],0.1162729768313091
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34553,90,1.22 [0.88-1.69],0.2347048275550504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",34899,436,1.14 [0.97-1.34],0.1201101207232604
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",34912,449,1.14 [0.97-1.35],0.1019720572740669
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19609,570,0.96 [0.81-1.13],0.5996655098776228
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",15614,190,0.99 [0.75-1.33],0.9662951607332024
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34552,89,0.93 [0.60-1.45],0.7550180291791851
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,38555,1300,1.12 [1.02-1.24],0.0217042742444761
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",40932,566,0.94 [0.79-1.12],0.4748380031495836
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,42279,205,0.95 [0.71-1.26],0.7080001921853083
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43205,191,1.00 [0.75-1.33],0.9756294442235116
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Rectum,42739,117,0.99 [0.69-1.43],0.9729035386947928
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43209,110,1.10 [0.78-1.54],0.5948338278360724
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Stomach,43295,82,1.18 [0.82-1.70],0.3838052409213511
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm,42834,504,1.04 [0.88-1.23],0.6080111318418104
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43216,191,1.05 [0.80-1.37],0.7275868761221846
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43225,152,1.20 [0.93-1.56],0.1673441749398324
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43121,90,0.89 [0.57-1.40],0.6182241645870299
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma, any site",43126,89,0.90 [0.57-1.40],0.6304794708930563
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi,42974,327,0.87 [0.69-1.11],0.2660312373233676
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,43240,147,0.64 [0.42-0.97],0.036310449021699
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Other benign neoplasms of skin,43051,306,1.02 [0.82-1.27],0.8289288378551158
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of breast,23388,120,1.19 [0.89-1.59],0.2493815217802859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Leiomyoma of uterus,22970,852,1.03 [0.90-1.17],0.6823757838724922
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,41185,323,1.20 [1.00-1.44],0.0445057868876621
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,40639,565,1.18 [1.03-1.36],0.0186306969896305
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,40639,565,1.18 [1.03-1.36],0.0186306969896305
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),37511,740,1.00 [0.87-1.16],0.9514515538830282
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,42366,119,1.20 [0.90-1.60],0.2111572047899647
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,42799,130,1.21 [0.92-1.59],0.1797372721457085
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,35013,1899,1.00 [0.91-1.10],0.9908302544079276
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,40788,900,1.13 [1.01-1.27],0.0407426270622719
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,39381,200,1.20 [0.95-1.52],0.1265612853637593
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Peripheral artery disease,41302,187,1.28 [1.01-1.63],0.0422499454070463
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39361,180,1.25 [0.98-1.58],0.0674387932924767
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,40080,899,1.13 [0.99-1.29],0.0660038796849573
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,40054,873,1.12 [0.98-1.28],0.0869011217906981
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,40108,295,1.10 [0.87-1.40],0.4378276954918947
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",40111,292,1.10 [0.86-1.40],0.4529995680485917
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,34729,1615,0.99 [0.89-1.10],0.7900795466220334
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",33320,206,1.10 [0.85-1.43],0.4627785448716097
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,34612,1498,0.96 [0.86-1.07],0.4737166976003955
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,33195,81,1.15 [0.78-1.69],0.4829444107073384
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",33243,129,0.98 [0.69-1.41],0.933506717546624
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Any mental disorder,36680,1088,1.06 [0.95-1.19],0.2995769089213836
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",35986,394,0.79 [0.62-1.01],0.0615925064029074
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",42625,290,0.76 [0.56-1.02],0.0696437527666756
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",42726,211,0.61 [0.42-0.91],0.0143259234505534
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,40302,98,0.88 [0.56-1.37],0.5679271490456717
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",43132,98,0.91 [0.58-1.42],0.6715554869390427
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",35690,98,0.89 [0.57-1.37],0.5951575042083223
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Alcohol dependence,40324,120,0.48 [0.28-0.83],0.0084152791304381
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Smoking dependency,40224,104,0.91 [0.60-1.39],0.6780430904098355
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",35690,98,1.21 [0.89-1.65],0.2205651012821853
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",36117,525,1.07 [0.91-1.26],0.3916811051481909
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Depression,40629,462,1.09 [0.92-1.29],0.3126529539564795
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Depression or dysthymia,35720,402,1.05 [0.88-1.27],0.5730159334219679
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",35804,212,1.19 [0.95-1.48],0.1277424523045175
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Other anxiety disorders,40831,110,1.07 [0.76-1.51],0.7075084869003905
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Neurological diseases,37253,2491,1.04 [0.96-1.13],0.293614344098953
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,33844,238,0.93 [0.72-1.21],0.5884894404383201
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43038,187,0.80 [0.57-1.12],0.1884978750908149
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,41087,800,1.06 [0.93-1.21],0.3874098063689608
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Epilepsy,40536,249,0.87 [0.66-1.15],0.3232879991569519
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Migraine,40422,135,0.69 [0.45-1.06],0.0867078227224807
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",42784,120,0.75 [0.48-1.15],0.1833976057821119
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Transient ischemic attack,41929,130,1.39 [1.09-1.76],0.0075405949312241
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other sleep disorders,40564,277,1.08 [0.87-1.35],0.4709880765099417
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Sleep apnoea,42343,211,1.10 [0.85-1.40],0.4702011914495052
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",41332,1115,0.97 [0.86-1.09],0.5704304645282798
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",40424,207,0.88 [0.65-1.18],0.383716928930064
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,40859,642,0.98 [0.84-1.14],0.7756173380168112
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,42819,140,1.00 [0.72-1.39],0.9900294769970188
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hemiplegia,42777,98,1.01 [0.69-1.50],0.9417067105998914
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other neurological diseases,42466,203,1.32 [1.08-1.61],0.0064447546502597
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42178,629,1.08 [0.94-1.25],0.2733235777675147
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,41910,361,1.10 [0.90-1.33],0.351008073011762
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,41680,131,1.10 [0.82-1.49],0.5222474858310822
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,41748,199,1.04 [0.80-1.36],0.7549888494136875
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,41677,128,0.98 [0.68-1.39],0.8891634326463151
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,37295,262,1.06 [0.83-1.34],0.6543799298584881
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,37708,675,0.96 [0.81-1.12],0.5780614277792557
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,41602,343,0.80 [0.62-1.03],0.0799425642876608
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,42726,68,0.98 [0.60-1.60],0.9249421637617417
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,3665,68,0.95 [0.56-1.62],0.8461932628995308
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",39129,68,1.00 [0.61-1.64],0.9942147171431506
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,42143,155,0.93 [0.66-1.31],0.6799916296486525
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42069,81,0.92 [0.57-1.47],0.7303801889076706
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",42119,140,0.81 [0.55-1.19],0.2933531707232926
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,42374,170,1.14 [0.87-1.48],0.3427317661431662
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,43106,221,1.02 [0.79-1.32],0.8807197329932314
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,41879,179,1.02 [0.77-1.36],0.8846201986302963
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,30623,5403,1.01 [0.95-1.08],0.6780778509969897
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,42248,116,1.19 [0.87-1.62],0.2780108090477713
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, essential",32287,3716,1.02 [0.95-1.10],0.5571320947762177
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertension,32326,3755,1.02 [0.95-1.09],0.6496207079900099
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28660,89,0.79 [0.48-1.31],0.3639898424568942
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",39638,1957,1.03 [0.94-1.13],0.54925160025793
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Angina pectoris,38852,1171,1.12 [1.00-1.25],0.0421586179426628
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41534,387,1.07 [0.88-1.30],0.4758944571028943
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,41921,774,1.00 [0.86-1.15],0.9623607416239888
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43060,162,0.70 [0.47-1.05],0.0829822127876009
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",38168,487,0.91 [0.75-1.11],0.3556733168620281
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,39192,1539,1.03 [0.93-1.15],0.5775512475932938
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Pulmonary embolism,41889,188,1.09 [0.83-1.42],0.5292909792198193
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Venous thromboembolism,42091,395,1.24 [1.05-1.45],0.0097312072317892
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Secondary right heart disease,41866,165,1.28 [1.01-1.62],0.0430119059860171
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,41868,167,1.27 [1.00-1.61],0.0477688696052448
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",28729,158,1.29 [1.01-1.64],0.0413318533407516
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiomyopathy,36044,101,1.32 [0.97-1.80],0.080358764671292
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Conduction disorders,36146,203,1.03 [0.78-1.36],0.8244323480987499
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,23957,191,1.09 [0.84-1.42],0.5243875034394787
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,24499,733,1.05 [0.90-1.21],0.5557967243274899
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arrhythmias,36057,114,1.02 [0.70-1.48],0.9260287558867604
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,36102,159,1.06 [0.78-1.44],0.7179449777720623
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Heart failure, strict",41536,347,0.94 [0.75-1.19],0.6236772537024576
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",41797,253,0.92 [0.70-1.20],0.5338268411237919
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",41855,213,0.92 [0.69-1.24],0.5942727997132696
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",41984,185,0.86 [0.61-1.19],0.3550271089624486
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41292,127,0.94 [0.65-1.37],0.7544686893213041
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,41386,221,1.40 [1.16-1.69],0.0005198298654039
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),40832,244,1.30 [1.07-1.57],0.0075047646136375
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,DVT of lower extremities,40793,205,1.27 [1.02-1.57],0.0292171830316768
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",42916,197,1.27 [1.02-1.58],0.0291959720726505
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Varicose veins,41395,807,1.02 [0.89-1.17],0.7636288415970807
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypotension,41344,135,1.08 [0.79-1.48],0.6393168535647629
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,34587,3492,1.02 [0.95-1.09],0.6724694500995232
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,42963,186,1.28 [1.03-1.59],0.0267879999232519
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Influenza and pneumonia,40229,384,1.14 [0.95-1.36],0.1630751033490802
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",40178,333,1.05 [0.86-1.30],0.6205062377461764
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,41734,436,1.05 [0.87-1.26],0.6211605908642746
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,41727,429,1.06 [0.88-1.27],0.526699264544978
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,41914,1031,0.91 [0.80-1.04],0.1615127130583999
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic sinusitis,41047,164,0.99 [0.73-1.34],0.953395022804194
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Nasal polyp,41093,210,0.82 [0.60-1.12],0.2189231182167251
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",41534,651,0.93 [0.79-1.09],0.3753537214184859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Deviated nasal septum,41189,306,0.87 [0.68-1.11],0.26782260230925
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,19947,104,1.05 [0.72-1.53],0.8144568896443751
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,38635,1709,0.99 [0.90-1.10],0.9082326540590344
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Early onset COPD,41317,297,0.94 [0.74-1.21],0.6482699789340446
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",41357,337,0.93 [0.74-1.18],0.560184211239997
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",41357,337,0.93 [0.74-1.18],0.560184211239997
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",40334,1405,0.97 [0.87-1.08],0.6231702886743107
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Asthma,30929,1405,0.97 [0.87-1.08],0.5888243845990389
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",30487,1405,0.97 [0.87-1.08],0.5652757131599765
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",30907,1383,0.98 [0.88-1.09],0.6938982926416342
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,42643,172,1.42 [1.16-1.75],0.000762692233459
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Interstitial lung disease,40731,134,1.47 [1.18-1.82],0.0006459849719871
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",42777,134,1.46 [1.18-1.82],0.0006621883756672
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,40718,121,1.40 [1.09-1.79],0.008265526375008
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural effusion,39809,182,1.08 [0.82-1.42],0.5909757304807957
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of pleura,40026,399,1.15 [0.96-1.37],0.1220615686332524
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,41164,185,1.22 [0.96-1.55],0.1017170473858871
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,29496,9772,1.01 [0.96-1.06],0.6042552855779544
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42396,705,0.89 [0.76-1.05],0.1593690671472222
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43231,150,0.81 [0.56-1.17],0.2595335930743988
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impacted teeth,43237,139,0.83 [0.58-1.21],0.3335355056733451
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Dental caries,41877,186,1.10 [0.85-1.43],0.4524514554491698
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,41856,165,0.89 [0.64-1.24],0.4927030062528026
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43214,167,0.86 [0.62-1.19],0.3634952585903234
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,41846,155,0.66 [0.44-1.00],0.0502033182642916
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41414,129,0.98 [0.69-1.40],0.9162629678755486
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43094,89,0.98 [0.64-1.50],0.9413148698017488
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,32977,449,0.85 [0.69-1.06],0.1425838139501107
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",36170,3642,1.03 [0.96-1.10],0.4386842617171697
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophagitis,33099,571,1.00 [0.85-1.18],0.9655018892629652
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,33716,1188,1.07 [0.96-1.19],0.2378312077941612
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,32654,126,1.17 [0.87-1.58],0.3037683081394355
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,32882,354,1.06 [0.87-1.30],0.5441900215795678
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophageal obstruction,32624,96,0.60 [0.35-1.04],0.0698712539844134
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastric ulcer,32772,244,0.89 [0.67-1.18],0.4151580686437134
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Duodenal ulcer,32741,213,0.98 [0.74-1.29],0.8682684055515344
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43062,150,1.05 [0.77-1.43],0.7759191815947957
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic gastritis,32738,210,0.89 [0.66-1.21],0.4568289707428306
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),33889,1361,0.99 [0.89-1.11],0.9013266360834912
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of appendix,43017,216,0.83 [0.61-1.12],0.2259126111465794
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Functional dyspepsia,33269,741,0.96 [0.82-1.11],0.5821531313335047
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,32808,280,1.04 [0.83-1.31],0.7448301302100095
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43004,273,1.00 [0.79-1.26],0.9903790962680922
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute appendicitis,42976,175,0.93 [0.69-1.27],0.6623447066672105
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Hernia,37951,2726,1.07 [0.99-1.15],0.0978261382831735
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Inguinal hernia,36235,1010,0.94 [0.82-1.07],0.3650493218073091
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Umbilical hernia,35429,204,0.98 [0.74-1.31],0.912541663912336
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ventral hernia,35388,163,1.13 [0.85-1.49],0.3981445797778137
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,36681,1456,1.12 [1.01-1.23],0.0244873482596868
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,41648,1285,1.03 [0.92-1.14],0.6353220612115746
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestines,33950,3371,1.03 [0.96-1.11],0.3620228515213618
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",42721,102,0.59 [0.35-1.00],0.0484867231683544
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",43177,139,0.77 [0.52-1.14],0.1902360933868326
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn disease,40502,139,0.77 [0.52-1.15],0.1977600527712653
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn's disease NAS,40468,105,0.89 [0.59-1.34],0.5713477097402218
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",43060,234,1.01 [0.78-1.30],0.9436314359729816
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcerative colitis,40597,234,1.01 [0.79-1.30],0.9351665786261144
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",40571,208,1.01 [0.77-1.32],0.9692313978487214
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,41407,1044,1.07 [0.95-1.20],0.2524285157972036
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41395,1032,1.08 [0.96-1.21],0.2127556066494557
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,30747,168,1.11 [0.84-1.45],0.464988018504623
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal stricture,42508,168,1.11 [0.84-1.46],0.4619628241968773
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",30691,112,1.05 [0.74-1.49],0.7962434693976873
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,31580,1001,1.01 [0.89-1.15],0.8643081282538441
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,30858,279,1.10 [0.89-1.36],0.3736961206731264
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,31051,472,1.07 [0.91-1.27],0.4066150879657976
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Constipation,40600,424,1.08 [0.90-1.29],0.4086588557878488
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of peritoneum,42538,148,0.69 [0.46-1.04],0.079143953353323
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,30829,250,0.98 [0.76-1.26],0.885554875037358
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,30704,125,0.96 [0.67-1.39],0.8423444935366434
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,32068,1489,1.01 [0.91-1.12],0.7999269087733888
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestine,31047,468,0.93 [0.76-1.13],0.4629308366921703
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,42515,125,0.69 [0.45-1.08],0.1064988653667952
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of liver,41899,203,1.12 [0.88-1.44],0.3603222139308563
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of liver,41808,112,1.35 [1.04-1.76],0.0259167816195234
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",40960,1035,0.96 [0.85-1.09],0.5486848745429365
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholelithiasis,40754,829,0.96 [0.84-1.11],0.5883718202481503
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholecystitis,40090,165,0.70 [0.48-1.03],0.0709044772813886
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40003,78,1.29 [0.94-1.79],0.1196375067418146
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis,40036,111,1.09 [0.77-1.53],0.6229668861792186
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),42982,111,1.09 [0.78-1.54],0.6117497510749849
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of the digestive system,40952,519,1.15 [0.99-1.34],0.0706188249230278
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal malabsorption,40547,114,1.57 [1.27-1.94],2.796925142447256e-05
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Coeliac disease,40528,95,1.63 [1.30-2.03],1.722693693239448e-05
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40514,81,1.05 [0.69-1.60],0.8081020070540504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,40767,334,0.96 [0.76-1.20],0.7134049923921975
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,GI-bleeding,40755,322,0.98 [0.78-1.22],0.8299996209816208
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,38025,2632,1.02 [0.94-1.10],0.6075696307750276
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,42524,181,1.08 [0.82-1.41],0.601423964364487
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,42585,774,1.11 [0.97-1.26],0.1199491906717218
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,40647,972,1.02 [0.90-1.16],0.7576383054320177
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,41751,675,0.94 [0.80-1.10],0.4475266989242974
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41229,153,0.76 [0.51-1.12],0.1675917395631984
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,41504,428,0.99 [0.82-1.21],0.9521297139456096
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,42805,153,0.77 [0.53-1.13],0.1892373984061007
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,42769,117,0.83 [0.55-1.27],0.3928755776872469
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,42742,90,0.95 [0.62-1.47],0.8226963621588794
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,41911,100,1.17 [0.83-1.63],0.3683599656472556
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42426,615,1.09 [0.95-1.26],0.2270925571644718
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,39832,157,0.92 [0.66-1.29],0.6443404480494913
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,39840,165,1.01 [0.75-1.36],0.9408832381071124
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,39803,128,0.95 [0.66-1.36],0.7715310654513504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40043,368,0.92 [0.74-1.15],0.4534416498224435
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40008,333,0.93 [0.74-1.17],0.5355829093892353
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,31206,6718,1.01 [0.95-1.06],0.8483539183388595
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,33921,3905,1.02 [0.96-1.09],0.50612429893519
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,38997,2045,0.92 [0.84-1.01],0.0838701452558718
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30278,262,1.19 [0.98-1.46],0.0833353665375637
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,30784,768,1.05 [0.91-1.21],0.4875925593637192
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",42570,251,1.23 [1.01-1.50],0.0396278528006787
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,42586,227,1.26 [1.03-1.54],0.0273426162622769
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,31942,1926,1.03 [0.94-1.13],0.4902180039845358
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",36260,1926,1.03 [0.94-1.13],0.5391293067474326
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,30130,114,1.17 [0.84-1.62],0.358519923734324
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",42347,110,1.17 [0.84-1.62],0.3587604887300442
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,30373,357,0.87 [0.68-1.10],0.2329369260267658
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,30133,117,1.09 [0.78-1.53],0.6008239831236382
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,30500,484,1.16 [0.99-1.36],0.0654101036183842
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43000,244,1.06 [0.84-1.35],0.6223528052079446
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,30901,885,0.94 [0.82-1.09],0.4204476425123555
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,30663,647,0.97 [0.83-1.14],0.7461378125030123
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,32195,2179,0.98 [0.89-1.07],0.5872930844336932
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30136,120,0.92 [0.63-1.34],0.6639449702162421
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30410,394,1.05 [0.87-1.27],0.5916966656791353
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30106,90,1.19 [0.84-1.68],0.3277580223076636
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30117,101,1.17 [0.84-1.63],0.3565498949221395
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,30831,815,0.97 [0.84-1.12],0.6538022445877452
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,30722,706,0.99 [0.85-1.15],0.8776555856499829
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,33487,470,1.06 [0.89-1.26],0.5023383709327811
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42322,242,1.31 [1.08-1.58],0.0057466188970712
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42177,97,1.34 [1.00-1.79],0.0488906731589866
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,37450,111,0.68 [0.42-1.10],0.1134129401967033
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,37853,514,0.87 [0.72-1.06],0.1730750966922182
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,38915,1576,0.92 [0.83-1.03],0.1422238372436655
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,37666,327,0.86 [0.68-1.11],0.2467429059502736
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,37485,146,0.77 [0.52-1.15],0.2012170994231813
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",38586,1247,0.95 [0.85-1.07],0.4009377166889963
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37424,85,0.85 [0.52-1.37],0.4961827642434415
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,37745,406,0.92 [0.74-1.13],0.4174250481935517
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,37512,173,0.99 [0.73-1.33],0.9242028149646204
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37466,127,0.90 [0.62-1.32],0.5897386397098027
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,37567,228,0.83 [0.61-1.12],0.2168771531806722
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37447,108,1.32 [1.01-1.74],0.045555352853161
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,37868,529,0.93 [0.77-1.11],0.4029669579192677
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,37482,530,0.81 [0.67-0.99],0.0435152187911765
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37066,114,0.88 [0.59-1.33],0.5538800506179681
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37102,150,0.93 [0.66-1.31],0.6672077833974644
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37124,172,0.75 [0.52-1.07],0.115049987400141
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37040,88,1.28 [0.93-1.75],0.1282175052720331
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37145,193,0.94 [0.69-1.27],0.67500285997996
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37126,174,1.00 [0.74-1.35],0.9862556890879244
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,37384,432,1.01 [0.84-1.22],0.9028425697208372
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37046,94,1.08 [0.74-1.58],0.6719848941202639
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37078,126,0.99 [0.69-1.42],0.965618680694317
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37158,206,0.83 [0.60-1.14],0.2439549282492735
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37060,108,0.75 [0.48-1.19],0.2249156534781791
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",37716,764,0.90 [0.77-1.05],0.1983793386763102
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,37243,291,0.86 [0.66-1.12],0.2592711192532618
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,37368,416,0.95 [0.77-1.16],0.593901136701529
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,40133,294,1.12 [0.91-1.37],0.2997351115733521
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,40489,650,1.03 [0.89-1.20],0.6634308059155476
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,39919,80,0.79 [0.47-1.33],0.3828401214950551
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,39933,94,0.93 [0.61-1.42],0.7535182343926068
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40006,167,1.07 [0.81-1.42],0.6336226111323724
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,34488,7171,1.02 [0.96-1.07],0.5488814030352218
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17117,1048,1.01 [0.89-1.15],0.8933394891715813
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,39103,357,1.01 [0.81-1.24],0.9563065147989048
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,38851,105,0.96 [0.64-1.43],0.8325381948380396
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Acute renal failure,39326,74,1.23 [0.83-1.81],0.2951756174067566
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,39328,76,1.23 [0.84-1.79],0.2905518255089933
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39344,92,1.05 [0.71-1.57],0.8005008655259709
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urolithiasis,42660,402,1.11 [0.93-1.32],0.2637194647175893
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,42579,105,0.87 [0.57-1.34],0.5383373610569777
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,42548,290,1.15 [0.94-1.40],0.1805571657140006
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42402,144,1.12 [0.83-1.50],0.4550353442342043
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,39621,1764,1.01 [0.92-1.11],0.8430968446406947
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cystitis,38008,151,0.88 [0.62-1.26],0.4945196398064384
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,37991,134,1.01 [0.72-1.41],0.9656627077781296
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,38308,451,1.06 [0.89-1.27],0.5223064279768943
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urethral stricture,38050,193,1.15 [0.90-1.47],0.2599243967651724
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,39018,1161,0.98 [0.87-1.10],0.7452256185990873
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,16531,462,0.88 [0.71-1.09],0.2411902293480275
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16158,89,1.04 [0.70-1.57],0.8332945078880897
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydrocele,16156,87,1.11 [0.75-1.64],0.5938538347939375
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16201,132,1.18 [0.88-1.58],0.2779818959459118
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16201,132,1.13 [0.83-1.55],0.4349588261721999
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16240,171,1.13 [0.86-1.48],0.3713314911760669
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23177,417,1.00 [0.83-1.20],0.9749875671958728
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22888,128,0.91 [0.63-1.31],0.6068980984968337
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,22902,142,1.17 [0.89-1.54],0.2704384033169504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22864,104,0.82 [0.53-1.27],0.3713552538270257
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23118,479,1.04 [0.88-1.23],0.6206660003289759
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,22754,115,1.14 [0.83-1.55],0.4218224783211046
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22853,214,1.13 [0.90-1.42],0.2943067112097566
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21385,3943,1.00 [0.93-1.07],0.9529391732490564
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Endometriosis,17743,301,0.94 [0.75-1.18],0.5877839179112365
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17527,85,0.82 [0.52-1.31],0.4105960692372705
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17578,136,0.94 [0.67-1.32],0.7178226128074197
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18127,685,1.12 [0.98-1.28],0.1013059874943568
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17785,343,0.93 [0.75-1.16],0.5313246063206887
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18259,817,0.99 [0.86-1.13],0.854796726011031
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17714,272,1.05 [0.84-1.30],0.6925033708658863
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17820,378,1.02 [0.84-1.24],0.8446430809116139
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17527,85,0.74 [0.45-1.22],0.2371897892027626
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17606,164,1.11 [0.85-1.44],0.4402845958537094
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23403,228,1.20 [0.97-1.48],0.0948349327328532
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23412,216,1.19 [0.96-1.48],0.1084414948698134
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23432,117,1.31 [1.01-1.70],0.0421954729641129
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23424,129,1.30 [1.01-1.67],0.0384133327126414
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17567,125,1.21 [0.91-1.60],0.1918282753293616
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17545,103,0.90 [0.59-1.35],0.6045711659080817
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17563,121,0.82 [0.54-1.22],0.3262889487932248
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Irregular menses,23345,396,1.02 [0.85-1.23],0.8172728054091853
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18597,1155,1.03 [0.92-1.15],0.6258720017906969
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18197,755,1.01 [0.88-1.15],0.9385249419341098
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23421,172,1.02 [0.77-1.35],0.880561128125581
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17838,396,0.99 [0.82-1.20],0.9090573079797216
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17710,268,1.06 [0.86-1.31],0.5698883985348336
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18223,781,1.02 [0.88-1.17],0.8333969083825421
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Female infertility,17529,87,0.79 [0.49-1.26],0.3224725870999481
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17522,80,0.83 [0.52-1.33],0.4390929821071172
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23429,723,0.93 [0.79-1.08],0.3335643507784767
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23435,988,0.85 [0.74-0.99],0.0317957476316758
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23430,384,0.89 [0.72-1.10],0.2967377568046401
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23155,109,0.79 [0.51-1.21],0.273151166335132
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23202,156,0.74 [0.51-1.07],0.1089903477478918
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23180,134,1.20 [0.92-1.57],0.1815348984644421
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23445,140,0.98 [0.71-1.34],0.8805680791849739
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23447,139,0.97 [0.70-1.33],0.830826054583045
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23444,355,0.84 [0.66-1.05],0.1314498029455337
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23193,104,0.85 [0.57-1.28],0.4459596518416188
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23289,200,0.70 [0.50-0.99],0.0446439520322046
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,22829,123,1.25 [0.95-1.64],0.1105623781292347
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,22874,168,1.19 [0.94-1.52],0.1556732748471849
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,22908,202,0.91 [0.68-1.20],0.4962894310209049
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,22831,125,0.69 [0.45-1.06],0.0919146811013173
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,22821,115,0.84 [0.57-1.25],0.3901272871158104
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,22825,119,0.70 [0.46-1.08],0.1110123745685216
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22638,191,0.81 [0.59-1.12],0.2098744486887918
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],22809,362,0.86 [0.69-1.08],0.1966604006632802
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,22997,550,0.84 [0.69-1.01],0.0670529813439583
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23449,143,0.83 [0.58-1.19],0.3116167140914457
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22248,110,0.76 [0.49-1.17],0.2130138322021142
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22528,81,1.02 [0.69-1.52],0.9112318462639032
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23455,277,0.96 [0.76-1.21],0.7027189851675711
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23393,215,0.81 [0.60-1.09],0.1732213244648218
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23444,208,0.83 [0.61-1.12],0.2159943937694735
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23434,198,0.76 [0.55-1.06],0.1015963834461388
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",42634,103,0.98 [0.65-1.46],0.9051355833090527
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Falls/tendency to fall,39114,994,0.95 [0.84-1.08],0.4624187756617622
